首页> 外文期刊>Prescrire international >Metoclopramide, domperidone: sudden cardiac death, ventricular arrhythmia
【24h】

Metoclopramide, domperidone: sudden cardiac death, ventricular arrhythmia

机译:甲基氯普胺,DOMPERIDONE:突然的心脏死亡,心间心律失常

获取原文
获取原文并翻译 | 示例
           

摘要

The results of two large epidemio-logical studies on the association between domperidone and ventricular arrhythmia or sudden cardiac death were published in 2015; one study was conducted in Taiwan and the other in the United Kingdom. They also examined metoclopramide. Both studies demonstrated an increased risk of sudden cardiac death and ventricular arrhythmia with metoclopramide, similar to the risk associated with domperidone. The results concerning domperidone were consistent with those of previous studies. In particular, they showed that the risk was higher with doses greater than 30 mg per day or with concomitant use of inhibitors of the cytochrome P450 isoenzyme CYP3A4, which reduce domperidone clearance. In practice, metoclopramide has a marginal role in patient care, with minor efficacy. Domperidone should not be used at all; its efficacy at the approved dose, beyond a placebo effect, is uncertain.
机译:2015年发表了两项关于多潘立酮与室性心律失常或心源性猝死之间关系的大型流行病学研究结果;一项研究在台湾进行,另一项在英国进行。他们还检查了甲氧氯普胺。两项研究均表明,甲氧氯普胺增加了心源性猝死和室性心律失常的风险,与多潘立酮的风险相似。多潘立酮的结果与之前的研究结果一致。特别是,他们表明,每天剂量超过30毫克或同时使用细胞色素P450同功酶CYP3A4抑制剂(可降低多潘立酮清除率)的风险更高。在实践中,甲氧氯普胺在患者护理中的作用微乎其微,疗效甚微。多潘立酮完全不应该使用;除了安慰剂效应外,其在批准剂量下的疗效尚不确定。

著录项

  • 来源
    《Prescrire international》 |2016年第175期|共3页
  • 作者

  • 作者单位
  • 收录信息
  • 原文格式 PDF
  • 正文语种 eng
  • 中图分类 药学;
  • 关键词

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号